Cynthia Tung

Company: Boehringer Ingelheim

Job title: Medical Director Ophthalmology

Seminars:

Panel Discussion Is 2024 the Year of Dry AMD?: Evaluating Current Safety, Delivery & Regulatory Challenges, Recent Successes with Approved GA Drugs & the Future of Dry AMD & GA Drug Development 9:00 am

Discussing the potential of targeting multiple pathways, such as complement and inflammasomes, with a single drug to halt disease progression Exploring the potential of combination therapies to tackle multifaceted challenges and revolutionize treatment paradigms for early, intermediate and late AMD Uncovering novel preclinical models that can recapitulate the macular microenvironment in dry AMD and GA…Read more

day: Conference Day 1

Delving Into Boehringer Ingelheim’s pipeline: Strategy and stages of development 9:30 am

Integrating multi-disciplinary research and technology to preserve vision and enhance life quality Targeting vascular, neuronal, and inflammatory mechanisms in retinal diseases Exploring various routes of administration for AMDRead more

day: Conference Day 1